Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neglected Scientific Research Deserves Immediate Attention

This article was originally published in PharmAsia News

Executive Summary

Financial Express (Bangladesh) (04/04/07) Azad, Qazi

You may also be interested in...

Pink Sheet Podcast: Merck’s Frazier Speaks Out, US FDA’s Hahn On Decisions, Operation Warp Speed, Worries About User Fee Goal Delays

Pink Sheet reporters and editor discuss Merck CEO Ken Frazier’s thoughts on racial inequity, FDA Commissioner’s explanation of coronavirus decision-making and Operation Warp Speed changes, and consider fears about the potential for user fee goal delays.

Device Week, 5 June 2020 – Medtech Recovery Beyond COVID-19 & A New $100M Pandemic Innovation Fund

On this week’s podcast the commercial team discuss strategies medtech companies can take to recover from the impact of COVID-19, and a new $100m Pandemic Innovation Fund launched by Israeli investment firm OurCrowd.

How To Use Digital Technology For EU Drug Approvals

Early interaction with the European Medicines Agency is recommended if companies are planning to incorporate digital technologies into their drug development plans. 




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts